BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
The Current P/E Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is -7.42.
Share Price | ₹29.7 | Apr 19,2024 |
Market Cap | ₹128.2 Cr | |
Earnings-TTM | ₹-17.3 Cr | TTM-Standalone Results |
Price/Earnings | -7.42x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹128.2 Cr] as on Apr 19,2024
(/) Earnings [ ₹-17.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -7.42x ]
Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay -7.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.
Historical PE (Price/Earnings) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PE Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio peaked in Mar2023 at 0x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -17.27 | -7.42 | 128.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.60 | 365,311.0 |
CIPLA LTD | 3,744.03 | 29.01 | 108,623.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.03 | 99,134.3 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 31.41 | 92,794.9 |
DIVIS LABORATORIES LTD | 1,382.97 | 70.43 | 97,408.4 |
MANKIND PHARMA LTD | 1,743.30 | 53.67 | 93,565.4 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 57.47 | 85,858.5 |
LUPIN LTD | 1,809.74 | 38.96 | 70,506.8 |
AUROBINDO PHARMA LTD | 2,777.89 | 22.93 | 63,697.4 |
ABBOTT INDIA LTD | 1,145.58 | 48.47 | 55,528.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -7.42x |
Max industry PE | 70.43x |
Median industry PE | 38.96x |
Average industry PE | 36.78x |
You may also like the below Video Courses